Invokana and Rabeprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Invokana (canagliflozin) and Rabeprazole (rabeprazole sodium). Common drug interactions include clumsiness among females and abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people have when they take Invokana and Rabeprazole. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Invokana?

Invokana has active ingredients of canagliflozin. It is often used in diabetes. eHealthMe is studying from 29,937 Invokana users. Check the latest studies of Invokana.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.

On Jul, 11, 2026

28 people who take Invokana and Rabeprazole together, and have interactions are studied.

Invokana and Rabeprazole drug interactions.

What are the common drug interactions of Invokana and Rabeprazole, by gender? *:

female:

Clumsiness (a lack of coordination or elegance)
Distractibility (inability to sustain one's attention)
Disturbance in attention
Gait disturbance
Hypoaesthesia (reduced sense of touch or sensation)
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Suicidal ideation
Acute myocardial infarction (acute heart attack)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Anaemia (lack of blood)

male:

Abdominal pain upper
Fatigue (feeling of tiredness)
Constipation
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Diarrhoea
Energy increased
Flatulence (flatus expelled through the anus)
Frequent bowel movements
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Haemorrhoidal haemorrhage (bleeding from the haemorrhoids)

What are the common drug interactions of Invokana and Rabeprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Abdominal pain upper
Acidosis (build-up of carbon dioxide in the blood)
Anion gap increased
Burning sensation
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Clavicle fracture
Clumsiness (a lack of coordination or elegance)
Crying
Dehydration (dryness resulting from the removal of water)
Disability

60+:

Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Diarrhoea
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Chills (felling of cold)
Constipation
Energy increased
Flatulence (flatus expelled through the anus)
Frequent bowel movements
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Haemorrhoidal haemorrhage (bleeding from the haemorrhoids)

What are the existing conditions these people have? *

Type 2 Diabetes: 6 people, 21.43%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 17.86%
Carcinoid Tumor: 3 people, 10.71%
High Blood Cholesterol: 2 people, 7.14%
Cardiac Disorder: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Invokana and Rabeprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously